Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients

OBJECTIVE: Sorafenib is a recommended treatment for advanced hepatocellular carcinoma. The study is to evaluate the efficacy of sorafenib plus cyproheptadine compared with sorafenib alone in patients with advanced hepatocellular carcinoma. METHODS: A retrospective cohort study reviewed all consecuti...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Jpn J Clin Oncol
Hlavní autoři: Feng, Yu-Min, Feng, Chin-Wen, Lu, Chin-Li, Lee, Ming-Yang, Chen, Chi-Yi, Chen, Solomon Chih-Cheng
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4376992/
https://ncbi.nlm.nih.gov/pubmed/25646358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyv007
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky